ESC 365 - Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation

Back

ESC Premium Access

Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation - data from the RACE 3 study

Session: Atrial fibrillation - General 2

Topic: Treatment

Speaker: Miss B. Nguyen (Groningen, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Miss Bao-Oanh Nguyen

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

6 more presentations in this session

SGLT 2 inhibitor suppresses atrial fibrillation in the canine model of atrial fibrillation.

Speaker: Doctor R. Nishinarita (Tokyo, JP)

Access

Abstract

Slides

Association of left atrial size with ischemic and bleeding risk scores in patients with non-valvular atrial fibrillation

Speaker: Doctor L. Enriquez Rodriguez (Soria, ES)

Access

Abstract

Slides

How could non-vitamin k antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?

Speaker: Doctor T. Chao (Taipei, TW)

Access

Abstract

High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

Speaker: Doctor R. De Caterina (Pisa, IT)

Access

Abstract

Slides

Atrial fibrillation and risk of pulmonary arterial hypertension. Swedisk nationwide registry study

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)

Access

Abstract

Slides

Access the full session

Atrial fibrillation - General 2

Speakers: Miss B. Nguyen, Doctor R. Nishinarita, Doctor L. Enriquez Rodriguez, Doctor T. Chao, Doctor R. De Caterina...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources